FARMINGTON, Conn., March 19, 2013 \/PRNewswire-iReach\/ -- 2012 continued to see major advances that were enabled by nanotechnology. In medicine in particular the delivery methods wrapped within nanoparticles have advanced many new and traditional drugs further along the clinical trial pipeline. Nano-engineering has also increased its grip on semiconductor manufacturing, and a multitude of quality control subsystems. <\/p>\n
(Photo: http:\/\/photos.prnewswire.com\/prnh\/20130319\/CG79773<\/a>) <\/p>\n BCC Research's \"Nanotechnology Research Review\" provides an overview of the market for nanoparticles in the life sciences on a global basis including description of leading and emerging drug products, major players in nanoparticle drug delivery field and methods of nanoparticle formation. The report also provides an overview of nanocomposites, nanoparticles, nanoclays and nanotubes as well as carbon nanotubes. <\/p>\n Learn more and request free sample pages from the full report at http:\/\/www.giiresearch.com\/report\/bc228065-2011-nanotechnology-research-review.html<\/a> <\/p>\n In \"Global Nanotechnology Drug Delivery Market 2012-2016\", industry experts forecast that the nanotechnology drug delivery market will grow 73.97 percent through 2016. The key vendors dominating this space are IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc. <\/p>\n One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market. <\/p>\n Learn more and request free sample pages from the full report at http:\/\/www.giiresearch.com\/report\/infi264464-global-nanotechnology-drug-delivery-market.html<\/a> <\/p>\n Drug Discovery Chemistry 2013 is coming to San Diego on April 16, 2013. The event features six conferences in one location, more than 100 technical presentations, exclusive exhibit and poster viewing hours, interactive roundtable, breakout and panel discussions, case studies, best practices, 400 high-level participants, and dedicated networking opportunities. Learn more and register today at http:\/\/www.giiconference.com\/chi252870-2013\/<\/a> <\/p>\n Drug Discovery & Therapy World Congress 2013 is taking place this June in Boston. This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics. <\/p>\n For more information and to register visit http:\/\/www.giiconference.com\/eur243545-2013\/<\/a> <\/p>\n <\/p>\n See the original post here: <\/p>\n Nanotechnology Market Research Review and Conference Opportunities<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" FARMINGTON, Conn., March 19, 2013 \/PRNewswire-iReach\/ -- 2012 continued to see major advances that were enabled by nanotechnology. In medicine in particular the delivery methods wrapped within nanoparticles have advanced many new and traditional drugs further along the clinical trial pipeline. Continue reading